Product Development & Registration Flashcards
6 cards from real RAC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 Product Development & Registration flashcards as text
What is the primary goal of Phase 1 clinical trials?
Answer: Assess safety and dosing
Phase 1 clinical trials are the first stage of testing a new drug in humans, typically involving a small group of healthy volunteers or patients with the target condition. The primary goal is to assess the drug's safety, determine a safe dosage range, and understand how the drug is metabolized and excreted (pharmacokinetics). Efficacy is not the main focus at this early stage.
What does an NDA submission include?
Answer: Complete safety, efficacy, and manufacturing data
A New Drug Application (NDA) is a comprehensive submission to the FDA requesting approval to market a new drug in the U.S. It must include all data and information about the drug, including results from all clinical trials (safety and efficacy), detailed manufacturing processes, quality control information, and proposed labeling. The NDA demonstrates that the drug is safe and effective for its intended use.
Which regulatory document is used to gain permission to ship a drug across state lines before approval?
Answer: Investigational New Drug (IND)
An Investigational New Drug (IND) application is the regulatory document submitted to the FDA to obtain permission to conduct clinical trials in humans. This approval allows the sponsor to ship the investigational drug across state lines for the purpose of these clinical investigations. Without an approved IND, interstate commerce of an unapproved drug for human testing is prohibited.
Which phase of clinical trials focuses on therapeutic effectiveness?
Answer: Phase 2
Phase 2 clinical trials are designed to evaluate the drug's effectiveness for a specific indication in a larger group of patients, typically several hundred. This phase also continues to assess safety and determine the optimal dosage range. The primary focus is to gather preliminary data on whether the drug works as intended and to further characterize its side effects.
What is the role of a Common Technical Document (CTD)?
Answer: To harmonize regulatory submissions
The Common Technical Document (CTD) is an internationally agreed-upon format for organizing applications to regulatory authorities for the registration of medicines. Its primary role is to harmonize the structure and content of regulatory submissions across different regions, such as the US, Europe, and Japan. This standardization streamlines the review process and reduces the burden on pharmaceutical companies.
Which application pathway is used to market a generic drug in the U.S.?
Answer: ANDA
An Abbreviated New Drug Application (ANDA) is the specific application pathway used in the U.S. to gain approval for a generic drug. Unlike a New Drug Application (NDA), an ANDA does not require new clinical trials to prove safety and effectiveness, but rather demonstrates bioequivalence to an already approved brand-name drug. This allows generic drugs to be marketed at a lower cost once the patent on the brand-name drug expires.